Derek T. Chalmers serves as Executive at Cara Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Derek T. Chalmers has executed 58 insider transactions totaling $7.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 3, 2017 involved exercising options for 20,000 shares valued at $49.6K.
Derek T. Chalmers currently holds 991,405 shares of Cara Therapeutics, Inc. (CARA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Derek T. Chalmers has been a net seller of CARA stock. They have purchased $0 and sold $7.2M worth of shares.
Derek T. Chalmers's most recent insider trade was on Nov 3, 2017, when they sold 20,000 shares at $2.48 per share.
Get notified when new Form 4 filings are submitted
| $12.66 |
| Discretionary |
| Jul 14, 2017 | CARA | $376.3K | Sale | 25,000 | $15.05 | Discretionary |
| Jul 14, 2017 | CARA | $24.8K | Option Exercise | 10,000 | $2.48 | Discretionary |
| Mar 15, 2016 | CARA | $24.8K | Option Exercise | 10,000 | $2.48 | Discretionary |
| Jan 6, 2016 | CARA | $215.3K | Sale | 12,500 | $17.22 | Discretionary |
| Feb 5, 2014 | CARA | $0 | Conversion | 53,042 | $N/A | Discretionary |
| Feb 5, 2014 | CARA | $0 | Conversion | 80,000 | $N/A | Discretionary |